About 50 results
Open links in new tab
  1. alpha2-Agonists for Acute Alcohol Withdrawal - Page 4 - Medscape

    The earliest studies of clonidine in the treatment of alcohol withdrawal were limited by the use of concomitant medications. Bjorkqvist et al. evaluated the efficacy of a clonidine taper, 0.15 mg ...

  2. Study: Screening Prevents Alcohol Withdrawal Post-Surgery

    Sep 9, 2025 · The CIWA-AR is the Clinical Institute Withdrawal Assessment for Alcohol Withdrawal, a provider assessment made in a clinical setting; it is a 10-item assessment used to evaluate the …

  3. Looking Back: An Early IgA Case and How Care Has Evolved

    4 days ago · Dr Suneel Udani unfolds how one patient’s struggle with deteriorating IgA nephropathy now inspires hope as new therapies transform the therapeutic landscape.

  4. Empowering Patients in IgA Nephropathy Care - Medscape

    Jan 7, 2026 · Dr Gaia Coppock explores why involving patients in IgA nephropathy treatment decisions is transforming care and leading to better outcomes.

  5. Best Alcohol Withdrawal Care for Inpatients Still Elusive

    Apr 11, 2012 · Medical inpatients in alcohol withdrawal are often sicker than patients without comorbidities or concurrent illness, and there is little strong evidence directing their care.

  6. Should Patients With Thyroid Issues Take GLP-1s? It Depends

    Obesity and family practice experts share when it’s safe to prescribe GLP-1 receptor agonists to patients with thyroid problems and what conditions should preclude the medications.

  7. Lessons From West Philly: Community Model Bridges Care Gaps

    Jan 6, 2026 · The Community Wellness HUB, launched by Drexel University, aims to ‘heal, unite, and bridge’ healthcare to the local community.

  8. The Anatomical Truth Machine - Medscape

    Jan 9, 2026 · An expert in imaging and cardiology argues for a CT-first approach to chest pain to minimize unnecessary cardiac catheterizations and to better diagnose patients more quickly.

  9. Bupropion and alcohol-induced seizures - Medscape

    May 13, 2002 · Assistant Professor of Neurology, The Johns Hopkins University School of Medicine. Baltimore, Md. Alcohol-induced seizures are withdrawal phenomena and do not respond to chronic …

  10. FDA Approves Another Neulasta Biosimilar - Medscape

    Dec 3, 2025 · India-based firm Lupin has joined the pegfilgrastim parade with the FDA’s approval of Armlupeg (pegfilgrastim-unne), the seventh biosimilar for Amgen’s Neulasta approved in the US …